174 related articles for article (PubMed ID: 23143863)
1. Effect of the phytotherapeutic agent eviprostat on the bladder in a rat model of bladder overdistension/emptying.
Kawai Y; Oka M; Kyotani J; Oyama T; Matsumoto S; Kakizaki H
Neurourol Urodyn; 2013 Sep; 32(7):1031-7. PubMed ID: 23143863
[TBL] [Abstract][Full Text] [Related]
2. Suppression of bladder oxidative stress and inflammation by a phytotherapeutic agent in a rat model of partial bladder outlet obstruction.
Oka M; Fukui T; Ueda M; Tagaya M; Oyama T; Tanaka M
J Urol; 2009 Jul; 182(1):382-90. PubMed ID: 19447421
[TBL] [Abstract][Full Text] [Related]
3. Suppression of bladder overactivity and oxidative stress by the phytotherapeutic agent, Eviprostat, in a rat model of atherosclerosis-induced chronic bladder ischemia.
Matsui T; Oka M; Fukui T; Tanaka M; Oyama T; Sagawa K; Nomiya M; Yamaguchi O
Int J Urol; 2012 Jul; 19(7):669-75. PubMed ID: 22458726
[TBL] [Abstract][Full Text] [Related]
4. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate.
Oka M; Ueda M; Oyama T; Kyotani J; Tanaka M
Prostate; 2009 Sep; 69(13):1404-10. PubMed ID: 19489033
[TBL] [Abstract][Full Text] [Related]
5. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
[TBL] [Abstract][Full Text] [Related]
6. Eviprostat suppresses proinflammatory gene expression in the prostate of rats with partial bladder-outlet obstruction: a genome-wide DNA microarray analysis.
Tagaya M; Oka M; Ueda M; Takagaki K; Tanaka M; Ohgi T; Yano J
Cytokine; 2009 Sep; 47(3):185-93. PubMed ID: 19616448
[TBL] [Abstract][Full Text] [Related]
7. Eviprostat suppresses urinary oxidative stress in a rabbit model of partial bladder outlet obstruction and in patients with benign prostatic hyperplasia.
Matsumoto S; Hanai T; Matsui T; Oka M; Tanaka M; Uemura H
Phytother Res; 2010 Feb; 24(2):301-3. PubMed ID: 19585469
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms by which a phytotherapeutic drug influences bladder activity in rats.
Sugaya K; Nishijima S; Tasaki S; Kadekawa K; Miyazato M; Ogawa Y
J Urol; 2008 Feb; 179(2):770-4. PubMed ID: 18082195
[TBL] [Abstract][Full Text] [Related]
9. Improvement by phytotherapeutic agent of detrusor overactivity, down-regulation of pharmacological receptors and urinary cytokines in rats with cyclophosphamide induced cystitis.
Nasrin S; Masuda E; Kugaya H; Ito Y; Yamada S
J Urol; 2013 Mar; 189(3):1123-9. PubMed ID: 23000860
[TBL] [Abstract][Full Text] [Related]
10. Effects of silodosin, a selective α1A-adrenoceptor antagonist, on bladder blood flow and bladder function in a rat model of atherosclerosis induced chronic bladder ischemia without bladder outlet obstruction.
Goi Y; Tomiyama Y; Nomiya M; Sagawa K; Aikawa K; Yamaguchi O
J Urol; 2013 Sep; 190(3):1116-22. PubMed ID: 23545103
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic treatment with vardenafil, a phosphodiesterase 5 inhibitor, on female rat bladder in a partial bladder outlet obstruction model.
Matsumoto S; Hanai T; Uemura H; Levin RM
BJU Int; 2009 Apr; 103(7):987-90. PubMed ID: 19021615
[TBL] [Abstract][Full Text] [Related]
12. Effect of a single treatment with tadalafil on blood flow in lower urinary tract tissues in rat models of bladder overdistension/emptying and abdominal aorta clamping/release.
Yoshinaga R; Kawai Y; Oka M; Fuchikami C; Oyama T
Eur J Pharmacol; 2015 May; 754():92-7. PubMed ID: 25697472
[TBL] [Abstract][Full Text] [Related]
13. Editorial comment to suppression of bladder overactivity and oxidative stress by the phytotherapeutic agent, Eviprostat, in a rat model of atherosclerosis-induced chronic bladder ischemia.
Yamada S
Int J Urol; 2012 Jul; 19(7):675; author reply 675. PubMed ID: 22725604
[No Abstract] [Full Text] [Related]
14. Effect of silodosin, a selective α(1A)-adrenoceptor antagonist, on voiding behavior and bladder blood flow in a rat model of bladder outlet obstruction.
Goi Y; Tomiyama Y; Yokoyama A; Tatemichi S; Maruyama K; Kobayashi M; Yamaguchi O
Eur J Pharmacol; 2015 Oct; 764():489-496. PubMed ID: 26189024
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral Tadenan treatment on rabbit bladder structure and function after partial outlet obstruction.
Levin RM; Hass MA; Bellamy F; Horan P; Whitbeck K; Chow PH; Kung LS; Gosling J
J Urol; 2002 May; 167(5):2253-9. PubMed ID: 11956488
[TBL] [Abstract][Full Text] [Related]
16. Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis.
Sugimoto M; Oka M; Tsunemori H; Yamashita M; Kakehi Y
Prostate; 2011 Mar; 71(4):438-44. PubMed ID: 21254154
[TBL] [Abstract][Full Text] [Related]
17. Effect of age on hydrogen peroxide mediated contraction damage in the male rat bladder.
Aikawa K; Leggett R; Levin RM
J Urol; 2003 Nov; 170(5):2082-5. PubMed ID: 14532858
[TBL] [Abstract][Full Text] [Related]
18. The phytotherapeutic agent, eviprostat, suppresses stromal proliferation and inflammation even after establishment of nonbacterial prostatitis in the rat prostate.
Shibuya S; Xia Z; Sugimoto M; Ueda N; Haba R; Kakehi Y
Urology; 2014 Mar; 83(3):528-34. PubMed ID: 24581515
[TBL] [Abstract][Full Text] [Related]
19. Effects of varying degrees of partial bladder outlet obstruction on urinary bladder function of rats: A novel link to inflammation, oxidative stress and hypoxia.
Sezginer EK; Yilmaz-Oral D; Lokman U; Nebioglu S; Aktan F; Gur S
Low Urin Tract Symptoms; 2019 Apr; 11(2):O193-O201. PubMed ID: 29282885
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic treatment with cilostazol, a phosphodiesterase 3 inhibitor, on female rat bladder in a partial bladder outlet obstruction model.
Matsumoto S; Watanabe M; Hashizume K; Wada N; Hori J; Kita M; Iwata T; Kakizaki H
Urology; 2014 Mar; 83(3):675.e7-11. PubMed ID: 24581543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
